BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 27836923)

  • 1. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
    da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
    J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.
    Qin Y; Zhang H; Feng L; Wei H; Wu Y; Jiang C; Xu Z; Zhu H; Liu T
    Ann Med; 2022 Dec; 54(1):2627-2636. PubMed ID: 36148999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.
    Gondek LP; Tiu R; O'Keefe CL; Sekeres MA; Theil KS; Maciejewski JP
    Blood; 2008 Feb; 111(3):1534-42. PubMed ID: 17954704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.
    Gondek LP; Haddad AS; O'Keefe CL; Tiu R; Wlodarski MW; Sekeres MA; Theil KS; Maciejewski JP
    Exp Hematol; 2007 Nov; 35(11):1728-38. PubMed ID: 17920760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
    Gondek LP; Dunbar AJ; Szpurka H; McDevitt MA; Maciejewski JP
    PLoS One; 2007 Nov; 2(11):e1225. PubMed ID: 18030353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.
    Maciejewski JP; Tiu RV; O'Keefe C
    Br J Haematol; 2009 Sep; 146(5):479-88. PubMed ID: 19563474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of genome-wide analysis of copy number alterations and UPD in myelodysplastic syndromes using combined CGH - SNP arrays.
    Ahmad A; Iqbal MA
    Curr Med Chem; 2012; 19(22):3739-47. PubMed ID: 22680919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of single-nucleotide polymorphism array-based whole-genome analysis and uniparental disomy in myelodysplastic syndrome.
    Ou Y; Yang Y; Yu H; Zhang X; Liu M; Wu Y
    Int J Lab Hematol; 2021 Oct; 43(5):1062-1069. PubMed ID: 33650312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
    Tiu RV; Gondek LP; O'Keefe CL; Elson P; Huh J; Mohamedali A; Kulasekararaj A; Advani AS; Paquette R; List AF; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP
    Blood; 2011 Apr; 117(17):4552-60. PubMed ID: 21285439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics.
    Heinrichs S; Kulkarni RV; Bueso-Ramos CE; Levine RL; Loh ML; Li C; Neuberg D; Kornblau SM; Issa JP; Gilliland DG; Garcia-Manero G; Kantarjian HM; Estey EH; Look AT
    Leukemia; 2009 Sep; 23(9):1605-13. PubMed ID: 19387468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromes.
    O'Keefe CL; Tiu R; Gondek LP; Powers J; Theil KS; Kalaycio M; Lichtin A; Sekeres MA; Maciejewski JP
    Exp Hematol; 2007 Feb; 35(2):240-51. PubMed ID: 17258073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality.
    Hahm C; Mun YC; Seong CM; Han SH; Chung WS; Huh J
    Acta Haematol; 2013; 129(3):154-8. PubMed ID: 23208021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category.
    Huh J; Jung CW; Kim HJ; Kim YK; Moon JH; Sohn SK; Kim HJ; Min WS; Kim DH
    Genes Chromosomes Cancer; 2013 Jan; 52(1):44-55. PubMed ID: 23023762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is the Clinical Utility of Repeat SNP Array Testing in the Follow-up of Myeloid Neoplasms?: A Retrospective Analysis of 44 Patients With Serial SNP Arrays.
    Basha B; Smith J; Rogers HJ; Cook JR
    Am J Clin Pathol; 2017 Mar; 147(3):278-284. PubMed ID: 28395056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.
    Afable MG; Wlodarski M; Makishima H; Shaik M; Sekeres MA; Tiu RV; Kalaycio M; O'Keefe CL; Maciejewski JP
    Blood; 2011 Jun; 117(25):6876-84. PubMed ID: 21527527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide.
    Sugimoto Y; Sekeres MA; Makishima H; Traina F; Visconte V; Jankowska A; Jerez A; Szpurka H; O'Keefe CL; Guinta K; Afable M; Tiu R; McGraw KL; List AF; Maciejewski J
    J Hematol Oncol; 2012 Mar; 5():4. PubMed ID: 22390313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance.
    Evans AG; Ahmad A; Burack WR; Iqbal MA
    Mod Pathol; 2016 Oct; 29(10):1183-99. PubMed ID: 27389314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.